|
🐜
|
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
16 auth.
R. Shapiro,
A. Basu,
H. Tan,
E. Gray,
A. Kahn,
P. Randhawa,
N. Murase,
A. Zeevi,
A. Girnita,
D. Metes,
...
R. Ness,
D. Bass,
A. Demetris,
J. Fung,
A. Marcos,
T. Starzl
|
7 |
2005 |
7
🐜
|
|
🦁
|
HLA‐Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft Dysfunction
13 auth.
A. Girnita,
R. Duquesnoy,
S. Yousem,
A. Iacono,
T. Corcoran,
Manuela Buzoianu,
B. Johnson,
K. Spichty,
J. Dauber,
G. Burckart,
...
B. Griffith,
K. McCurry,
A. Zeevi
|
7 |
2005 |
7
🦁
|
|
🐜
|
Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition
13 auth.
R. C. Walsh,
P. Brailey,
A. Girnita,
R. Alloway,
A. Shields,
G. E. Wall,
B. Sadaka,
M. Cardi,
A. Tevar,
A. Govil,
...
G. Mogilishetty,
P. Roy-Chaudhury,
E. Woodle
|
7 |
2011 |
7
🐜
|
|
🦁
|
HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
12 auth.
A. Girnita,
K. McCurry,
A. Iacono,
R. Duquesnoy,
T. Corcoran,
M. Awad,
...
K. Spichty,
S. Yousem,
G. Burckart,
J. Dauber,
B. Griffith,
A. Zeevi
|
7 |
2004 |
7
🦁
|
|
🐜
|
Prospective Iterative Trial of Proteasome Inhibitor‐Based Desensitization
13 auth.
E. Woodle,
A. Shields,
N. Ejaz,
B. Sadaka,
A. Girnita,
R. C. Walsh,
R. Alloway,
P. Brailey,
M. Cardi,
B. A. Jawdeh,
...
P. Roy-Chaudhury,
A. Govil,
G. Mogilishetty
|
7 |
2015 |
7
🐜
|
|
🐜
|
Graft Versus Host Disease in Intestinal Transplantation
10 auth.
G. Mazariegos,
K. Abu-Elmagd,
R. Jaffe,
G. Bond,
R. Sindhi,
L. Martin,
...
C. Macedo,
J. Peters,
A. Girnita,
J. Reyes
|
6 |
2004 |
6
🐜
|
|
🐜
|
Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.
10 auth.
K. McCurry,
A. Iacono,
A. Zeevi,
S. Yousem,
A. Girnita,
S. Husain,
...
D. Zaldonis,
B. Johnson,
B. Hattler,
T. Starzl
|
6 |
2005 |
6
🐜
|
|
🐜
|
Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches.
13 auth.
O. Adeyi,
A. Girnita,
J. Howe,
M. Marrari,
Y. Awadalla,
M. Askar,
J. Martell,
A. Zeevi,
R. Shapiro,
M. Nalesnik,
...
P. Randhawa,
A. Demetris,
R. Duquesnoy
|
6 |
2005 |
6
🐜
|
|
🐬
|
Proteasome inhibitor-based therapy for antibody-mediated rejection.
R. C. Walsh,
R. Alloway,
A. Girnita,
E. Woodle
|
6 |
2012 |
6
🐬
|
|
🐜
|
Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
10 auth.
R. Duquesnoy,
Y. Awadalla,
J. Lomago,
L. Jelinek,
J. Howe,
D. Zern,
...
B. Hunter,
J. Martell,
A. Girnita,
A. Zeevi
|
6 |
2008 |
6
🐜
|
